531 related articles for article (PubMed ID: 11781246)
1. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
[TBL] [Abstract][Full Text] [Related]
2. The role of interleukin 13 in classical Hodgkin lymphoma.
Skinnider BF; Kapp U; Mak TW
Leuk Lymphoma; 2002 Jun; 43(6):1203-10. PubMed ID: 12152987
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Skinnider BF; Elia AJ; Gascoyne RD; Trümper LH; von Bonin F; Kapp U; Patterson B; Snow BE; Mak TW
Blood; 2001 Jan; 97(1):250-5. PubMed ID: 11133768
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 13: a growth factor in hodgkin lymphoma.
Skinnider BF; Kapp U; Mak TW
Int Arch Allergy Immunol; 2001 Dec; 126(4):267-76. PubMed ID: 11815733
[TBL] [Abstract][Full Text] [Related]
5. Lymphomagenesis in Hodgkin lymphoma.
Matsuki E; Younes A
Semin Cancer Biol; 2015 Oct; 34():14-21. PubMed ID: 25725205
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology of Hodgkin lymphoma.
Küppers R
Hematology Am Soc Hematol Educ Program; 2009; ():491-6. PubMed ID: 20008234
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity.
Hinz M; Lemke P; Anagnostopoulos I; Hacker C; Krappmann D; Mathas S; Dörken B; Zenke M; Stein H; Scheidereit C
J Exp Med; 2002 Sep; 196(5):605-17. PubMed ID: 12208876
[TBL] [Abstract][Full Text] [Related]
8. Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.
Natoli A; Lüpertz R; Merz C; Müller WW; Köhler R; Krammer PH; Li-Weber M
Int J Cancer; 2013 Oct; 133(8):1945-54. PubMed ID: 23553437
[TBL] [Abstract][Full Text] [Related]
9. Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist.
Oshima Y; Puri RK
Cell Immunol; 2001 Jul; 211(1):37-42. PubMed ID: 11585386
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells.
Stanelle J; Döring C; Hansmann ML; Küppers R
Blood; 2010 Nov; 116(20):4202-11. PubMed ID: 20660789
[TBL] [Abstract][Full Text] [Related]
11. IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats.
Roy B; Bhattacharjee A; Xu B; Ford D; Maizel AL; Cathcart MK
J Leukoc Biol; 2002 Sep; 72(3):580-9. PubMed ID: 12223527
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo.
Trieu Y; Wen XY; Skinnider BF; Bray MR; Li Z; Claudio JO; Masih-Khan E; Zhu YX; Trudel S; McCart JA; Mak TW; Stewart AK
Cancer Res; 2004 May; 64(9):3271-5. PubMed ID: 15126369
[TBL] [Abstract][Full Text] [Related]
13. Constitutive overexpression of a novel 21 kDa protein by Hodgkin lymphoma and aggressive non-Hodgkin lymphomas.
Zhou M; Fadlelmola FM; Cohn JB; Skinnider B; Gascoyne RD; Banerjee D
Mol Cancer; 2008 Jan; 7():12. PubMed ID: 18218123
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma.
Martini M; Hohaus S; Petrucci G; Cenci T; Pierconti F; Massini G; Teofili L; Leone G; Larocca LM
Am J Clin Pathol; 2008 Mar; 129(3):472-7. PubMed ID: 18285272
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.
Weber-Nordt RM; Egen C; Wehinger J; Ludwig W; Gouilleux-Gruart V; Mertelsmann R; Finke J
Blood; 1996 Aug; 88(3):809-16. PubMed ID: 8704235
[TBL] [Abstract][Full Text] [Related]
16. STAT3 is constitutively activated in Hodgkin cell lines.
Kube D; Holtick U; Vockerodt M; Ahmadi T; Haier B; Behrmann I; Heinrich PC; Diehl V; Tesch H
Blood; 2001 Aug; 98(3):762-70. PubMed ID: 11468177
[TBL] [Abstract][Full Text] [Related]
17. STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.
Kis LL; Gerasimcik N; Salamon D; Persson EK; Nagy N; Klein G; Severinson E; Klein E
Blood; 2011 Jan; 117(1):165-74. PubMed ID: 20876453
[TBL] [Abstract][Full Text] [Related]
18. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Martinez RL; Alkan S
Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
[TBL] [Abstract][Full Text] [Related]
19. Analysis of a clonally related mantle cell and Hodgkin lymphoma indicates Epstein-Barr virus infection of a Hodgkin/Reed-Sternberg cell precursor in a germinal center.
Tinguely M; Rosenquist R; Sundström C; Amini RM; Küppers R; Hansmann ML; Bräuninger A
Am J Surg Pathol; 2003 Nov; 27(11):1483-8. PubMed ID: 14576485
[TBL] [Abstract][Full Text] [Related]
20. Midkine expression in Reed-Sternberg cells of Hodgkin's disease.
Kato H; Watanabe K; Murari M; Isogai C; Kinoshita T; Nagai H; Ohashi H; Nagasaka T; Kadomatsu K; Muramatsu H; Muramatsu T; Saito H; Mori N; Murate T
Leuk Lymphoma; 2000 Apr; 37(3-4):415-24. PubMed ID: 10752993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
